May 16, 2018 - By Gregory Tomko

AOXING PHARMACEUTICAL CO INC (OTCMKTS:AOXG) reported an increase of 200% in short interest. FINRA published in May AOXG’s total 900 short interest. That’s 200% up from 300 shares.

AOXG reached $0.0564 during the last trading session after $0.0001 change.Aoxing Pharmaceutical Company, Inc. has volume of 2,000 shares. Since May 16, 2017 AOXG has 0.00% and is . AOXG underperformed the S&P500 by 11.55%.

Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China.The firm is worth $4.30 million. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain.Currently it has negative earnings. The Company’s products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.